DOI:

Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography

Shuzou Tanimoto, MD; Jiro Aoki, MD; Patrick W. Serruys, MD, PhD; Evelyn Regar*, MD, PhD

A 73-year-old woman with hypertension, hyperlipidemia and positive familial history of coronary artery disease presented with Canadian Cardiovascular Society class III angina and underwent coronary angiography, which showed a chronic occluded right coronary artery (Panel A). The vessel was recanalized and treated with three paclitaxel-eluting stents (TAXUS®, Boston Scientific: 3.5 x 32 mm distally, 3.5 x 28 mm in the middle part, 3.5 x 12 mm proximally). Postintervention coronary angiography showed a good result (Panel B). Twelve-month follow-up angiography revealed focal in-stent restenosis (Panel C). Intracoronary optical coherence tomography (OCT: LightLabImaging™, Boston, MA, USA) pullback displayed well-expanded stents covered with a thin, homogenous, highly reflective neointimal layer (Panel D, E). In contrast, the narrowest lesion site (minimal lumen area 1.1 mm2; stent area 9.0 mm2) showed a three-layer appearance of the neointima (Panel F). The inner luminal layer appeared concentric, homogenous and signal-rich (maximal thickness 0.27 mm). A second layer consisting of a low-reflective area with poorly delineated borders followed. The third layer was in direct contact with the stent struts and revealed only minimal signal intensity. These signal-poor areas (maximal thickness 1.18 mm) might represent acellular fibrinoid deposition that has been well described in experimental studies. The patient was re-treated with repeat paclitaxel-eluting stent implantation.

OCT is an analogue of intravascular ultrasound with an ultra-high resolution (10 µm) superior to any current available imaging modalities. This imaging device may be useful in visualizing neointimal growth in drug-eluting stents and improve our understanding of its underlying physiopathology in the future.

Volume 1 Number 4
Feb 20, 2006
Volume 1 Number 4
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-25-01133 Nov 16, 2025
Five-Year Outcomes of the Early-Generation Intrepid Transapical Transcatheter Mitral Valve Replacement System
Tang G et al
free

Editorial

10.4244/EIJ-E-25-00046 Nov 14, 2025
HALT – an evolving understanding of the mechanisms of formation and clinical relevance
Leipsic J and Khoo J
free

Editorial

10.4244/EIJ-E-25-00041 Nov 14, 2025
Transcatheter aortic valve alignment: substantial progress, remaining gaps
Amat-Santos I and Pensotti F
free

Viewpoint

10.4244/EIJ-D-25-00692 Nov 14, 2025
Discontinuation of the ACURATE transcatheter heart valve platform: loss or reckoning?
Kim W and Möllmann H
free

State-of-the-Art

10.4244/EIJ-D-24-01069 Nov 14, 2025
Transcatheter treatment of bicuspid aortic valve stenosis
Tchétché D et al
free

Original Research

10.4244/EIJ-D-25-00682 Nov 14, 2025
Long-term outcomes and durability of balloon-expandable TAVI in small and large annuli
Yamamoto M et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved